TuHURA Biosciences, Inc. Email Format
Biotechnology ResearchFlorida, United States11-50 Employees
TuHURA Biosciences, Inc. is a biotechnology company focused on immuno-oncology. Based in Tampa, Florida, the company is at the Phase 3 registration stage, developing therapies intended to overcome resistance to cancer immunotherapies, including checkpoint inhibitors and cellular treatments. Its work targets cancers where immunotherapies fail or lose efficacy, with the aim of expanding the benefits of these treatments to more patients. One development highlighted in 2026 is TBS-2025, progressing toward Phase 1b/2 in a defined subset of AML patients. The company has also engaged with the investment community through industry conferences in May 2026.